These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 11090053

  • 1. Lentiviral gene transfer into primary and secondary NOD/SCID repopulating cells.
    Woods NB, Fahlman C, Mikkola H, Hamaguchi I, Olsson K, Zufferey R, Jacobsen SE, Trono D, Karlsson S.
    Blood; 2000 Dec 01; 96(12):3725-33. PubMed ID: 11090053
    [Abstract] [Full Text] [Related]

  • 2. High levels of transgene expression following transduction of long-term NOD/SCID-repopulating human cells with a modified lentiviral vector.
    Gao Z, Golob J, Tanavde VM, Civin CI, Hawley RG, Cheng L.
    Stem Cells; 2001 Dec 01; 19(3):247-59. PubMed ID: 11359950
    [Abstract] [Full Text] [Related]

  • 3. Lentiviral vector transduction of NOD/SCID repopulating cells results in multiple vector integrations per transduced cell: risk of insertional mutagenesis.
    Woods NB, Muessig A, Schmidt M, Flygare J, Olsson K, Salmon P, Trono D, von Kalle C, Karlsson S.
    Blood; 2003 Feb 15; 101(4):1284-9. PubMed ID: 12393514
    [Abstract] [Full Text] [Related]

  • 4. Transduction of human hematopoietic stem cells by lentiviral vectors pseudotyped with the RD114-TR chimeric envelope glycoprotein.
    Di Nunzio F, Piovani B, Cosset FL, Mavilio F, Stornaiuolo A.
    Hum Gene Ther; 2007 Sep 15; 18(9):811-20. PubMed ID: 17824830
    [Abstract] [Full Text] [Related]

  • 5. Lentiviral gene transfer and ex vivo expansion of human primitive stem cells capable of primary, secondary, and tertiary multilineage repopulation in NOD/SCID mice. Nonobese diabetic/severe combined immunodeficient.
    Piacibello W, Bruno S, Sanavio F, Droetto S, Gunetti M, Ailles L, Santoni de Sio F, Viale A, Gammaitoni L, Lombardo A, Naldini L, Aglietta M.
    Blood; 2002 Dec 15; 100(13):4391-400. PubMed ID: 12453876
    [Abstract] [Full Text] [Related]

  • 6. Transduction of human CD34+ CD38- bone marrow and cord blood-derived SCID-repopulating cells with third-generation lentiviral vectors.
    Guenechea G, Gan OI, Inamitsu T, Dorrell C, Pereira DS, Kelly M, Naldini L, Dick JE.
    Mol Ther; 2000 Jun 15; 1(6):566-73. PubMed ID: 10933981
    [Abstract] [Full Text] [Related]

  • 7. Long-term engraftment of nonobese diabetic/severe combined immunodeficient mice with human CD34+ cells transduced by a self-inactivating human immunodeficiency virus type 1 vector.
    Gatlin J, Padgett A, Melkus MW, Kelly PF, Garcia JV.
    Hum Gene Ther; 2001 Jun 10; 12(9):1079-89. PubMed ID: 11399229
    [Abstract] [Full Text] [Related]

  • 8. Comparison of three retroviral vector systems for transduction of nonobese diabetic/severe combined immunodeficiency mice repopulating human CD34+ cord blood cells.
    Leurs C, Jansen M, Pollok KE, Heinkelein M, Schmidt M, Wissler M, Lindemann D, Von Kalle C, Rethwilm A, Williams DA, Hanenberg H.
    Hum Gene Ther; 2003 Apr 10; 14(6):509-19. PubMed ID: 12718762
    [Abstract] [Full Text] [Related]

  • 9. High-level transduction and gene expression in hematopoietic repopulating cells using a human immunodeficiency [correction of imunodeficiency] virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter.
    Demaison C, Parsley K, Brouns G, Scherr M, Battmer K, Kinnon C, Grez M, Thrasher AJ.
    Hum Gene Ther; 2002 May 01; 13(7):803-13. PubMed ID: 11975847
    [Abstract] [Full Text] [Related]

  • 10. Enhanced transgene expression in cord blood CD34(+)-derived hematopoietic cells, including developing T cells and NOD/SCID mouse repopulating cells, following transduction with modified trip lentiviral vectors.
    Sirven A, Ravet E, Charneau P, Zennou V, Coulombel L, Guétard D, Pflumio F, Dubart-Kupperschmitt A.
    Mol Ther; 2001 Apr 01; 3(4):438-48. PubMed ID: 11319904
    [Abstract] [Full Text] [Related]

  • 11. Identification of parameters required for efficient lentiviral vector transduction and engraftment of human cord blood CD34(+) NOD/SCID-repopulating cells.
    Liu Y, Hangoc G, Campbell TB, Goodman M, Tao W, Pollok K, Srour EF, Broxmeyer HE.
    Exp Hematol; 2008 Aug 01; 36(8):947-56. PubMed ID: 18640494
    [Abstract] [Full Text] [Related]

  • 12. Lentiviral-mediated gene transfer into haematopoietic stem cells.
    Woods NB, Mikkola H, Nilsson E, Olsson K, Trono D, Karlsson S.
    J Intern Med; 2001 Apr 01; 249(4):339-43. PubMed ID: 11298854
    [Abstract] [Full Text] [Related]

  • 13. Transduction of umbilical cord blood CD34+ NOD/SCID-repopulating cells by simian foamy virus type 1 (SFV-1) vector.
    Zucali JR, Ciccarone T, Kelley V, Park J, Johnson CM, Mergia A.
    Virology; 2002 Oct 25; 302(2):229-35. PubMed ID: 12441067
    [Abstract] [Full Text] [Related]

  • 14. Highly efficient transduction of the green fluorescent protein gene in human umbilical cord blood stem cells capable of cobblestone formation in long-term cultures and multilineage engraftment of immunodeficient mice.
    van Hennik PB, Verstegen MM, Bierhuizen MF, Limón A, Wognum AW, Cancelas JA, Barquinero J, Ploemacher RE, Wagemaker G.
    Blood; 1998 Dec 01; 92(11):4013-22. PubMed ID: 9834203
    [Abstract] [Full Text] [Related]

  • 15. Simplified retroviral vector gcsap with murine stem cell virus long terminal repeat allows high and continued expression of enhanced green fluorescent protein by human hematopoietic progenitors engrafted in nonobese diabetic/severe combined immunodeficient mice.
    Kaneko S, Onodera M, Fujiki Y, Nagasawa T, Nakauchi H.
    Hum Gene Ther; 2001 Jan 01; 12(1):35-44. PubMed ID: 11177540
    [Abstract] [Full Text] [Related]

  • 16. Molecular evidence of lentiviral vector-mediated gene transfer into human self-renewing, multi-potent, long-term NOD/SCID repopulating hematopoietic cells.
    Ailles L, Schmidt M, Santoni de Sio FR, Glimm H, Cavalieri S, Bruno S, Piacibello W, Von Kalle C, Naldini L.
    Mol Ther; 2002 Nov 01; 6(5):615-26. PubMed ID: 12409260
    [Abstract] [Full Text] [Related]

  • 17. Efficient retroviral-mediated gene transfer to human cord blood stem cells with in vivo repopulating potential.
    Conneally E, Eaves CJ, Humphries RK.
    Blood; 1998 May 01; 91(9):3487-93. PubMed ID: 9558409
    [Abstract] [Full Text] [Related]

  • 18. Targeting transgene expression to antigen-presenting cells derived from lentivirus-transduced engrafting human hematopoietic stem/progenitor cells.
    Cui Y, Golob J, Kelleher E, Ye Z, Pardoll D, Cheng L.
    Blood; 2002 Jan 15; 99(2):399-408. PubMed ID: 11781219
    [Abstract] [Full Text] [Related]

  • 19. Phenotype and function of human hematopoietic cells engrafting immune-deficient CB17-severe combined immunodeficiency mice and nonobese diabetic-severe combined immunodeficiency mice after transplantation of human cord blood mononuclear cells.
    Pflumio F, Izac B, Katz A, Shultz LD, Vainchenker W, Coulombel L.
    Blood; 1996 Nov 15; 88(10):3731-40. PubMed ID: 8916937
    [Abstract] [Full Text] [Related]

  • 20. Gene delivery to hematopoietic stem cells using lentiviral vectors.
    Miyoshi H.
    Methods Mol Biol; 2004 Nov 15; 246():429-38. PubMed ID: 14970608
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.